免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network.
Tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
TIL(肿瘤浸润淋巴细胞)的存在与原发性黑色素瘤(PM)预后良好相关。近期研究提出利用人工智能(AI)数字病理学方法,在苏木精-伊红染色全视野切片图像(WSI)上标准化评估TIL。
本研究采用一种新的卷积神经网络(CNN)分析PM的WSI,自动评估TIL浸润并提取TIL评分。该CNN在307例PM回顾性队列中训练和验证,包括训练集237张WSI、57,758个图像块,以及独立测试集70张WSI、29,533个图像块。通过依据图像块是否存在TIL进行分类,构建了基于AI的TIL密度指数(AI-TIL)。该CNN识别PM切片中TIL的表现良好,在测试集中特异性和敏感性均为100%。AI-TIL指数与传统TIL评估和临床结局相关,是与良好预后直接相关的独立预后标志物。全自动、标准化的AI-TIL在区分PM临床结局方面似乎优于传统方法。仍需进一步研究开发易用工具,帮助病理学家在实体瘤临床评估中判断TIL。
The presence of tumor-infiltrating lymphocytes (TILs) is associated with a favorable prognosis of primary melanoma (PM). Recently, artificial intelligence (AI)-based approach in digital pathology was proposed for the standardized assessment of TILs on hematoxylin and eosin-stained whole slide images (WSIs).
Herein, the study applied a new convolution neural network (CNN) analysis of PM WSIs to automatically assess the infiltration of TILs and extract a TIL score. A CNN was trained and validated in a retrospective cohort of 307 PMs including a training set (237 WSIs, 57,758 patches) and an independent testing set (70 WSIs, 29,533 patches). An AI-based TIL density index (AI-TIL) was identified after the classification of tumor patches by the presence or absence of TILs.
The proposed CNN showed high performance in recognizing TILs in PM WSIs, showing 100% specificity and sensitivity on the testing set. The AI-based TIL index correlated with conventional TIL evaluation and clinical outcome. The AI-TIL index was an independent prognostic marker associated directly with a favorable prognosis. A fully automated and standardized AI-TIL appeared to be superior to conventional methods at differentiating the PM clinical outcome.
Further studies are required to develop an easy-to-use tool to assist pathologists to assess TILs in the clinical evaluation of solid tumors.
MEMBER ACCOUNT
登录成功会直接打开下一页。